Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., explained in plain language.
-
New pill could ease psoriatic arthritis pain in weeks
Disease control Not yet recruitingThis study tests a new drug called TQH3906 for people with active psoriatic arthritis, a condition causing joint pain and skin patches. About 156 adults aged 18-70 will receive either the new drug, a placebo, or an active comparator to see if it improves symptoms like joint swell…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 17:42 UTC
-
New hope for Tough-to-Treat colorectal cancer: targeted drug TQB2102 enters phase 3 trial
Disease control Not yet recruitingThis study tests a new drug called TQB2102 in people with advanced colorectal cancer that has high levels of a protein called HER2 and has stopped responding to standard chemotherapies. About 142 participants will be randomly assigned to receive either TQB2102 or another standard…
Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC